FDA Declaration May Restart Compounders' Shortage Suit
By Dan McKay · December 19, 2024, 5:16 PM EST
Federal regulators pulled Eli Lilly's lucrative weight-loss and diabetes drug off the national shortage list Thursday and gave compounding pharmacists two months to stop making copycat versions of the injectable medication,...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login